These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30124149)

  • 1. Inhibition of RAGE Axis Signaling: A Pharmacological Challenge.
    Rojas A; Morales M; Gonzalez I; Araya P
    Curr Drug Targets; 2019; 20(3):340-346. PubMed ID: 30124149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
    Bongarzone S; Savickas V; Luzi F; Gee AD
    J Med Chem; 2017 Sep; 60(17):7213-7232. PubMed ID: 28482155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE and its ligands: from pathogenesis to therapeutics.
    Jangde N; Ray R; Rai V
    Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):555-575. PubMed ID: 32933340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Characteristics of RAGE and Advances in Small-Molecule Inhibitors.
    Kim HJ; Jeong MS; Jang SB
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
    Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
    Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ousting RAGE in melanoma: A viable therapeutic target?
    Syed DN; Aljohani A; Waseem D; Mukhtar H
    Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RAGE Signaling in Inflammatory Disease.
    Hudson BI; Lippman ME
    Annu Rev Med; 2018 Jan; 69():349-364. PubMed ID: 29106804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
    Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
    Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
    Shekhtman A; Ramasamy R; Schmidt AM
    Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging.
    Teissier T; Boulanger É
    Biogerontology; 2019 Jun; 20(3):279-301. PubMed ID: 30968282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular investigation of glycated insulin-induced insulin resistance via insulin signaling and AGE-RAGE axis.
    Walke PB; Bansode SB; More NP; Chaurasiya AH; Joshi RS; Kulkarni MJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166029. PubMed ID: 33248275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors.
    Singh H; Agrawal DK
    Drug Dev Res; 2022 Sep; 83(6):1257-1269. PubMed ID: 35781678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
    Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
    Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
    Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
    Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
    Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
    Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.
    Kinscherf NA; Pehar M
    Curr Drug Targets; 2022; 23(12):1191-1209. PubMed ID: 35702767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the receptor for advanced glycation end products and consequences on health.
    Wautier MP; Guillausseau PJ; Wautier JL
    Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE Signaling in Melanoma Tumors.
    Olaoba OT; Kadasah S; Vetter SW; Leclerc E
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RAGE Axis: A Relevant Inflammatory Hub in Human Diseases.
    Rojas A; Lindner C; Schneider I; Gonzalez I; Uribarri J
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.